VIRELIX tablet

Drug Labeling and Warnings

Drug Details [pdf]

Health Claim Section:

Virelix Multivitamin

Dispensed by Prescription

Description:

85622-533-30

Reserved for Professional Recommendation

Virelix Tablets should be administered under the supervision of a licensed medical practitioner.

Virelix Tablets are orally administered prescription dietary supplement tablets intended to provide significant amounts of Vitamins B1, B3, B6, B12, C, D3, folic acid, and NADH to supplement the diet and help assure that nutritional deficiencies of these vitamins will not develop.

This listed product is not a National Drug Code,but instead has merely been formatted to comply with standard industry practice for pharmacy and insurance computer systems.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician’s supervision. There are no implied or explicit claims on therapeutic equivalence.

Manufactured for:

Oncora Pharma

Dallas TX 75228

Warnings:

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Virelix Tablets should only be used under the direction and supervision of a licensed medical practitioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Dosage and Administration:

Adults: One tablet daily as a dietary supplement, preferably with a meal, or as recommended by a healthcare professional.

Precautions:

CONTRAINDICATIONS

This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

PRECAUTIONS

Use under the direction and supervision of a licensed healthcare professional.

ADVERSE REACTIONS

Allergic sensitization has been reported following oral administration of folic acid. Consult your physician immediately if adverse reactions occur.

KEEP OUT OF THE REACH OF CHILDREN.

Storage:

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F).

Label:

pdp

INGREDIENTS AND APPEARANCE

VIRELIX 
virelix tablet

Product Information
Product Type	DIETARY SUPPLEMENT	Item Code (Source)	NHRIC:85477-533
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R)	ASCORBIC ACID	125 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41)	CHOLECALCIFEROL	.125 mg
THIAMINE HYDROCHLORIDE (UNII: M572600E5P) (Thiamine ION - UNII:4ABT0J945J)	THIAMINE HYDROCHLORIDE	25 mg
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z)	PYRIDOXINE HYDROCHLORIDE	125 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8)	FOLIC ACID	1.667 mg
CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204)	CYANOCOBALAMIN	1 mg
NICOTINAMIDE ADENINE DINUCLEOTIDE (UNII: 0U46U6E8UK) (NICOTINAMIDE ADENINE DINUCLEOTIDE - UNII:0U46U6E8UK)	NICOTINAMIDE ADENINE DINUCLEOTIDE	5 mg
UBIQUINONE (UNII: EJ27X76M46) (UBIQUINONE - UNII:EJ27X76M46)	UBIQUINONE	50 mg

Inactive Ingredients
Ingredient Name	Strength
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
SILICA (UNII: ETJ7Z6XBU4)
HYDROXYPROPYL CELLULOSE (110000 WAMW) (UNII: 5Y0974F5PW)
MAGNESIUM STEARATE (UNII: 70097M6I30)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NHRIC:85477-533-30	30 in 1 PACKAGE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
DIETARY SUPPLEMENT		10/09/2025

Supplement Facts
Serving Size :		Serving per Container :
	Amount Per Serving	% Daily Value
color
scoring	1
shape
size (solid drugs)	18 mm

Labeler - Oncora Pharma, LLC (119482542)